Webinar: Target Deconvolution and Tractability Assessment

Target deconvolution, particularly when paired with proteomics techniques, plays a crucial role in drug discovery and target identification. By using chemical proteomics, researchers can more precisely identify interactions between small molecules and cellular targets.  In addition, multiplex target discovery and target tractability assessment can accelerate drug discovery by providing a more efficient, large-scale, data-driven approach.

In this webinar, experts discuss how to apply target discovery and target deconvolution technologies in the early stages of drug development to enable faster, more accurate identification of viable drug targets. Speakers also showcase the use of DNA-encoded libraries for target tractability assessment, a powerful tool for evaluating a target’s suitability for drug development.